Literature DB >> 27172973

The effects of bevacizumab on intestinal anastomotic healing in rabbits.

Hayato Nakamura1, Yukihiro Yokoyama2, Keisuke Uehara1, Toshio Kokuryo1, Junpei Yamaguchi1, Toyonori Tsuzuki3, Masato Nagino1.   

Abstract

PURPOSES: The aim of this study was to investigate the effects of the preoperative administration of BV on the healing process of intestinal anastomosis in a rabbit model.
METHODS: Twenty male white rabbits were randomly divided into two groups. The control group received saline 1 week before surgery, and the BV group received intravenous BV 1 week before surgery. Each rabbit underwent an enteroenterostomy and a colocolostomy. On postoperative day 7, the bursting pressures of the anastomoses, CD31 and α-smooth muscle actin (α-SMA) staining by immunohistochemistry, the gene expression of α-SMA, and collagen deposition using Picrosirius Red at the site of anastomosis were evaluated.
RESULTS: The bursting pressure of small bowel anastomoses was significantly lower in the BV group than in the control group (control 184 ± 10 mmHg vs. BV 140 ± 9 mmHg; p = 0.004). The microvessel counts in the anastomotic tissue were significantly lower in the BV group than in the control group in both the small bowel (p = 0.023) and colon (p = 0.008). The expression of α-SMA, and the degree of collagen deposition decreased in the anastomotic tissue in the BV group compared with the control group.
CONCLUSION: The preoperative use of BV may therefore negatively affect the rigidity of intestinal anastomosis.

Entities:  

Keywords:  Anastomotic leakage; Angiogenesis; Bevacizumab; Intestinal anastomotic healing; α-Smooth muscle actin

Mesh:

Substances:

Year:  2016        PMID: 27172973     DOI: 10.1007/s00595-016-1342-4

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  28 in total

Review 1.  Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy.

Authors:  R K Jain
Journal:  Nat Med       Date:  2001-09       Impact factor: 53.440

2.  Structure-function studies of two synthetic anti-vascular endothelial growth factor Fabs and comparison with the Avastin Fab.

Authors:  Germaine Fuh; Ping Wu; Wei-Ching Liang; Mark Ultsch; Chingwei V Lee; Barbara Moffat; Christian Wiesmann
Journal:  J Biol Chem       Date:  2005-12-22       Impact factor: 5.157

Review 3.  Growth factors and gastrointestinal anastomotic healing.

Authors:  Emile Rijcken; Larissa Sachs; Thomas Fuchs; Hans-Ullrich Spiegel; Philipp-Alexander Neumann
Journal:  J Surg Res       Date:  2013-10-12       Impact factor: 2.192

4.  Preclinical pharmacokinetics, interspecies scaling, and tissue distribution of a humanized monoclonal antibody against vascular endothelial growth factor.

Authors:  Y S Lin; C Nguyen; J L Mendoza; E Escandon; D Fei; Y G Meng; N B Modi
Journal:  J Pharmacol Exp Ther       Date:  1999-01       Impact factor: 4.030

5.  Neoadjuvant bevacizumab and irinotecan versus bevacizumab and temozolomide followed by concomitant chemoradiotherapy in newly diagnosed glioblastoma multiforme: A randomized phase II study.

Authors:  Kenneth F Hofland; Steinbjørn Hansen; Morten Sorensen; Silke Engelholm; Henrik P Schultz; Aida Muhic; Kirsten Grunnet; Anders Ask; Junia C Costa; Charlotte Kristiansen; Carsten Thomsen; Hans Skovgaard Poulsen; Ulrik Lassen
Journal:  Acta Oncol       Date:  2014-01-23       Impact factor: 4.089

6.  Collagenase activity in the gastro-intestinal tract.

Authors:  P R Hawley; W P Faulk; T K Hunt; J E Dunphy
Journal:  Br J Surg       Date:  1970-12       Impact factor: 6.939

7.  Colon cancer, version 3.2014.

Authors:  Al B Benson; Alan P Venook; Tanios Bekaii-Saab; Emily Chan; Yi-Jen Chen; Harry S Cooper; Paul F Engstrom; Peter C Enzinger; Moon J Fenton; Charles S Fuchs; Jean L Grem; Steven Hunt; Ahmed Kamel; Lucille A Leong; Edward Lin; Wells Messersmith; Mary F Mulcahy; James D Murphy; Steven Nurkin; Eric Rohren; David P Ryan; Leonard Saltz; Sunil Sharma; David Shibata; John M Skibber; Constantinos T Sofocleous; Elena M Stoffel; Eden Stotsky-Himelfarb; Christopher G Willett; Kristina M Gregory; Deborah A Freedman-Cass
Journal:  J Natl Compr Canc Netw       Date:  2014-07       Impact factor: 11.908

8.  Neoadjuvant oxaliplatin and capecitabine and bevacizumab without radiotherapy for poor-risk rectal cancer: N-SOG 03 Phase II trial.

Authors:  Keisuke Uehara; Kazuhiro Hiramatsu; Atsuyuki Maeda; Eiji Sakamoto; Masaya Inoue; Satoshi Kobayashi; Yuichiro Tojima; Yuichiro Yoshioka; Goro Nakayama; Hiroshi Yatsuya; Naoki Ohmiya; Hidemi Goto; Masato Nagino
Journal:  Jpn J Clin Oncol       Date:  2013-08-09       Impact factor: 3.019

9.  Is early post-operative treatment with 5-fluorouracil possible without affecting anastomotic strength in the intestine?

Authors:  B M van der Kolk; B M de Man; T Wobbes; T Hendriks
Journal:  Br J Cancer       Date:  1999-02       Impact factor: 7.640

10.  The effect of intravitreal bevacizumab and ranibizumab on cutaneous tensile strength during wound healing.

Authors:  John B Christoforidis; Jillian Wang; Angela Jiang; James Willard; Cedric Pratt; Mahmoud Abdel-Rasoul; Sashwati Roy; Heather Powell
Journal:  Clin Ophthalmol       Date:  2013-01-24
View more
  4 in total

1.  Impact of RAS/BRAF mutation status in locally advanced rectal cancer treated with preoperative chemotherapy.

Authors:  Taihei Oshiro; Keisuke Uehara; Toshisada Aiba; Toshiki Mukai; Tomoki Ebata; Masato Nagino
Journal:  Int J Clin Oncol       Date:  2018-02-24       Impact factor: 3.402

2.  The Science of Anastomotic Healing.

Authors:  Ryan B Morgan; Benjamin D Shogan
Journal:  Semin Colon Rectal Surg       Date:  2022-03-08

Review 3.  Late anastomotic breakdown with bevacizumab in colorectal cancers, a case-based review.

Authors:  T O'Hare; R McDermott; R Hannon
Journal:  Ir J Med Sci       Date:  2017-08-29       Impact factor: 1.568

4.  Bevacizumab-associated intestinal perforation and perioperative complications in patients receiving bevacizumab.

Authors:  Toshiaki Yoshimoto; Kozo Yoshikawa; Jun Higashijima; Tomohiko Miyatani; Takuya Tokunaga; Masaaki Nishi; Chie Takasu; Hideya Kashihara; Yukako Takehara; Mitsuo Shimada
Journal:  Ann Gastroenterol Surg       Date:  2020-02-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.